QurCan Therapeutics solves the problem of CNS and tissue-specific delivery of nucleotide and therapeutic molecules via its proprietary next generation nanoparticle platform, called "TERP".  QurCan's team is committed to restoring health and transforming the lives of patients through the development of nanomedicine that requires the unique features of the TERP technology to address major unmet needs for the treatment of cancer and other major diseases.